118 related articles for article (PubMed ID: 3491643)
1. Evidence for chemical differences in HLA-DR molecules on autologous acute lymphoblastic leukemia and B-lymphoblastoid cell lines.
Graf L; Pesando JM
Blood; 1987 Jan; 69(1):7-11. PubMed ID: 3491643
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
3. Two dimensional gel analysis of HLA-DR2 associated HLA-D clusters.
Nakatsuji T; Moriya K; Tsuji K
Tokai J Exp Clin Med; 1986 May; 11(2):125-31. PubMed ID: 3031855
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
5. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
6. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
7. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
9. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
10. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
12. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
13. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
18. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
19. [Detection of HLA-DR, DQ and DP loci on monocytes using monoclonal antibodies].
Májský A
Cas Lek Cesk; 1987 Oct; 126(42):1313-6. PubMed ID: 3677160
[No Abstract] [Full Text] [Related]
20. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
